G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 96 filers reported holding G1 THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $1,915,000 | -84.3% | 100,000 | -57.1% | 0.09% | -79.6% |
| Q3 2018 | $12,187,000 | -6.5% | 233,073 | -22.3% | 0.44% | -12.2% |
| Q2 2018 | $13,038,000 | +22.6% | 300,000 | +4.5% | 0.50% | +10.6% |
| Q1 2018 | $10,633,000 | +149.8% | 287,000 | +33.8% | 0.45% | +135.2% |
| Q4 2017 | $4,256,000 | -28.8% | 214,500 | -10.6% | 0.19% | -30.1% |
| Q3 2017 | $5,974,000 | +9.7% | 240,000 | -23.1% | 0.28% | +0.4% |
| Q2 2017 | $5,445,000 | – | 312,188 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 1,423,794 | $34,541,000 | 9.18% |
| Burrage Capital Management LLC | 373,876 | $9,070,000 | 6.35% |
| Birchview Capital, LP | 40,000 | $970,000 | 0.59% |
| 361 CAPITAL LLC | 47,325 | $1,148,000 | 0.54% |
| Rhenman & Partners Asset Management AB | 190,000 | $4,609,000 | 0.50% |
| CHI Advisors LLC | 44,000 | $1,067,000 | 0.42% |
| Bellevue Group AG | 721,925 | $17,514,000 | 0.25% |
| Candriam S.C.A. | 870,423 | $21,117,000 | 0.22% |
| Virtus ETF Advisers LLC | 18,991 | $461,000 | 0.22% |
| HHLR ADVISORS, LTD. | 949,431 | $23,033,000 | 0.21% |